Porcilis AR-T - Product Overview
Porcilis AR-T
Porcilis AR-T is an inactivated vaccine against Atrophic Rhinitis in pigs. It contains the toxoid of Pasteurella multocida dermo-necrotic toxin (DNT) and inactivated Bordetella bronchiseptica cells, in a water-in-oil adjuvant. Protection is transferred from the vaccinated sow or gilt to the piglets by maternally derived antibodies (MDA) through the intake of colostrum. Some other key information (trademarks - accreditations etc.) would go here if wanted.


More Info on Porcilis


Porcilis AR-T - Data Sheet
Product Class
Vaccines
Target Species
Pigs
Description
Porcilis AR-T is an inactivated vaccine against Atrophic Rhinitis in pigs. It contains the toxoid of Pasteurella multocida dermo-necrotic toxin (DNT) and inactivated Bordetella bronchiseptica cells, in a water-in-oil adjuvant. Protection is transferred from the vaccinated sow or gilt to the piglets by maternally derived antibodies (MDA) through the intake of colostrum.
Composition
Toxoid of Pasteurella multocida (DNT). Bordetella bronchiseptica cells. These active components are suspended in the aqueous phase of a water-in-oil emulsion.
Formulation
Ready-to-use inactivated vaccine.
Indications
Prevention of clinical signs of Atrophic Rhinitis in piglets by passive immunisation with antibodies derived from the sow or gilt through the intake of colostrum.
Vaccination
Pregnant sows and gilts: animals not previously vaccinated with Porcilis AR-T should be given two doses, 6 weeks apart. The first dose should be given at least 8 weeks before the expected farrowing date.

Non-pregnant sows and gilts: animals not previously vaccinated with Porcilis AR-T should be given two doses, 6-4 weeks apart. A third dose should be administered 2-4 weeks before the expected farrowing date.

Re-vaccination: a single dose should be given prior to each subsequent farrowing. Usually, this means a dose every 5 to 6 months. It is preferable to vaccinate sows and gilts during the second half of pregnancy, but not within two weeks of farrowing.
Method of administration
2 ml by the intramuscular route.
Withholding period
Nil
Presentation
Multi-dose vials containing 20 ml (10 doses) and 50 ml (25 doses).
Storage
Store at a temperature of 2-8�C. Protect from light. Do not freeze.
Contra-indications
After vaccination, a transient raise in body temperature may occur and a transient swelling may arise at the site of injection.
Further information
Precautions



Publication date: 1st June 2005